HUE048369T2 - Diagnosztikai eljárás végbélrák kimutatására - Google Patents

Diagnosztikai eljárás végbélrák kimutatására

Info

Publication number
HUE048369T2
HUE048369T2 HUE17181646A HUE17181646A HUE048369T2 HU E048369 T2 HUE048369 T2 HU E048369T2 HU E17181646 A HUE17181646 A HU E17181646A HU E17181646 A HUE17181646 A HU E17181646A HU E048369 T2 HUE048369 T2 HU E048369T2
Authority
HU
Hungary
Prior art keywords
diagnosis
colorectal cancer
colorectal
cancer
Prior art date
Application number
HUE17181646A
Other languages
English (en)
Inventor
Ondrej Slaby
Petra Vychytilova
Marek Svoboda
Milana Sachlova
Original Assignee
Univ Masarykova
Masarykuv Onkologicky Ustav
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Masarykova, Masarykuv Onkologicky Ustav filed Critical Univ Masarykova
Publication of HUE048369T2 publication Critical patent/HUE048369T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HUE17181646A 2017-07-17 2017-07-17 Diagnosztikai eljárás végbélrák kimutatására HUE048369T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17181646.5A EP3431609B1 (en) 2017-07-17 2017-07-17 Method of diagnosis of colorectal cancer

Publications (1)

Publication Number Publication Date
HUE048369T2 true HUE048369T2 (hu) 2020-07-28

Family

ID=59363020

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE17181646A HUE048369T2 (hu) 2017-07-17 2017-07-17 Diagnosztikai eljárás végbélrák kimutatására

Country Status (7)

Country Link
US (1) US20210130904A1 (hu)
EP (1) EP3431609B1 (hu)
JP (2) JP6989863B2 (hu)
ES (1) ES2785682T3 (hu)
HU (1) HUE048369T2 (hu)
PL (1) PL3431609T3 (hu)
WO (1) WO2019015702A1 (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
CA2881394C (en) 2012-08-13 2024-05-14 Cedars-Sinai Medical Center Exosomes and micro-ribonucleic acids for tissue regeneration
WO2016054591A1 (en) 2014-10-03 2016-04-07 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
EP3402543B1 (en) 2016-01-11 2021-09-08 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
US11351200B2 (en) 2016-06-03 2022-06-07 Cedars-Sinai Medical Center CDC-derived exosomes for treatment of ventricular tachyarrythmias
US11541078B2 (en) 2016-09-20 2023-01-03 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
US11759482B2 (en) 2017-04-19 2023-09-19 Cedars-Sinai Medical Center Methods and compositions for treating skeletal muscular dystrophy
PL3431609T3 (pl) * 2017-07-17 2020-11-02 Masarykova Univerzita Sposób diagnozowania raka jelita grubego
WO2019126068A1 (en) 2017-12-20 2019-06-27 Cedars-Sinai Medical Center Engineered extracellular vesicles for enhanced tissue delivery
CN111321222B (zh) * 2018-12-17 2024-01-19 北京大学肿瘤医院内蒙古医院(内蒙古医科大学附属肿瘤医院、内蒙古自治区肿瘤医院、内蒙古自治区癌症中心) 用于结直肠癌无创诊断的血清piRNA标志物及检测试剂盒
CN109913461B (zh) * 2019-04-01 2023-05-02 中国医科大学附属口腔医院 根尖牙乳头干细胞外泌体piRNA生物标志物及其筛选应用
CN115698286A (zh) * 2020-05-19 2023-02-03 西达-赛奈医疗中心 外泌体衍生的piwi-相互作用rna及使用其的方法
EP4130296A1 (en) * 2021-08-03 2023-02-08 Deutsches Krebsforschungszentrum - Stiftung des öffentlichen Rechts / Universität Heidelberg Cancer prediction

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7501243B2 (en) 2001-02-21 2009-03-10 Novartis Vaccines And Diagnostics, Inc. Detection of colon or breast cancer by measuring TTK polypeptide expression
WO2004071267A2 (en) 2003-02-11 2004-08-26 Roche Diagnostics Gmbh Diagnosis of colorectal cancer by detection of nicotinamide n-methyltransferase in a stool sample
WO2004079368A2 (en) 2003-03-08 2004-09-16 Auvation Ltd Markers for colorectal cancer
EP1654540A1 (en) 2003-08-07 2006-05-10 Roche Diagnostics GmbH Use of protein acidic ribosomal protein po (rla-0) as a marker for colorectal cancer
WO2005015234A1 (en) 2003-08-11 2005-02-17 Roche Diagnostics Gmbh Use of protein sahh as a marker for colorectal cancer
KR101073875B1 (ko) 2008-11-28 2011-10-14 한국생명공학연구원 대장암 진단 마커 및 이를 이용한 대장암 진단방법
WO2011161960A1 (en) * 2010-06-23 2011-12-29 Oncotherapy Science, Inc. C1orf59 for target genes of cancer therapy and diagnosis
CN103627705B (zh) * 2013-10-28 2016-02-24 南京医科大学 与膀胱癌相关的piRNA生物标志物及其应用
CN105483218B (zh) * 2015-12-11 2018-08-07 南京大学 检测和/或预测男性生殖功能障碍的精浆piRNA标志物或其组合及其应用
PL3431609T3 (pl) * 2017-07-17 2020-11-02 Masarykova Univerzita Sposób diagnozowania raka jelita grubego

Also Published As

Publication number Publication date
US20210130904A1 (en) 2021-05-06
JP6989863B2 (ja) 2022-01-12
JP2021090451A (ja) 2021-06-17
EP3431609B1 (en) 2020-02-12
EP3431609A1 (en) 2019-01-23
PL3431609T3 (pl) 2020-11-02
WO2019015702A1 (en) 2019-01-24
ES2785682T3 (es) 2020-10-07
JP2020527047A (ja) 2020-09-03

Similar Documents

Publication Publication Date Title
HUE048369T2 (hu) Diagnosztikai eljárás végbélrák kimutatására
HK1251408A1 (zh) 治療癌症的方法
IL275663A (en) Cancer treatment methods
HK1253093A1 (zh) 診斷和治療癌症的方法
ZA201804227B (en) Methods of treating cancer
GB2545361B (en) Methods of assessing colorectal cancer status
GB201511152D0 (en) Method of diagnosing bladder cancer
IL262005A (en) Methods of treating cancer in children
SG10201801562PA (en) Combination method for treatment of cancer
HK1247931A1 (zh) 用於診斷和治療癌症的組合物和方法
HK1253082A1 (zh) 診斷乳腺癌的方法
SG10201913528PA (en) Methods of diagnosing cancer
ZA201908539B (en) Method of treatment of cancer
EP3183578B8 (en) Methods for the early detection of colorectal cancer
IL267675A (en) A method for treating advanced cancer expressing her2
SG11201701076TA (en) Diagnosis of cancer
SG11202005163PA (en) Methods of treating cancer
GB201814350D0 (en) Diagnosis of cancer
GB201513989D0 (en) Method of diagnosis of dysphagia
GB201717945D0 (en) Method for treatment of cancer
HK1249134A1 (zh) 結直腸癌相關疾病的生物標誌物
PT3298165T (pt) Método e kit para diagnóstico de cancro colorretal
IL269123A (en) Methods of treating cancer
EP3389670A4 (en) METHODS OF TREATING BREAST CANCER
GB201513188D0 (en) Method of tomography